Effective January 1, 2017, CMS required Medicare plan sponsors to limit the daily cumulative dose of opioid products a beneficiary may obtain at Point of Sale (POS). The daily limit is referred to as the Morphine Equivalent Dose (MED) limit. The cumulative limit is based on a combination of drug strength and a product’s Morphine Milligram Equivalency (MME). The cumulative total daily MED value will be calculated based on the number of opioid drugs prescribed over a period of time which includes in coming claims and active claims history.

*Please see attached PDF for more information.